Almost all trials fail, but it's interesting that CRISPR is getting the nod. It has so many uses that if it doesn't work in this specific cancer study it doesn'

Almost all trials fail, but it's interesting that CRISPR is getting the nod. It has so many uses that if it doesn't work in this specific cancer study it doesn't really matter.